Últimos Artículos de Terapeuthic Advances in Endocrinology and Metabolism
- Contribution of DNA methylation predicted leptin to all-cause, cancer, and cardiovascular mortality among US adults aged 50 years and older: findings from NHANES 1999–2002
- Analysis of risk factors and establishment of a prediction model for latent autoimmune diabetes in adults
- Obesity indices as predictors of metabolic syndrome: 1-year findings from a Peruvian cohort of private educational institution workers
- Use of serum MKRN3 and DLK1 levels in precocious puberty: association with an MKRN3 pathogenic variant
- When HbA1c looks “too high”: two practical clarifications for endocrine screening in chelated β-thalassemia major
- Impacts of insulin storage and injection techniques intervention on glycemic control among patients with diabetes in northwest Ethiopia: a quasi-experimental study
- Diabetes management using a clinical guideline versus usual practice: a feasibility trial-based qualitative study among Ayurvedic practitioners and patients in Nepal
- Real-world experience with teplizumab in stage 2 type 1 diabetes: a plain language summary
- Clinical significance of meteorin-like protein in type 2 diabetes mellitus and its association with carotid plaque complications
- A case of immune thrombocytopenia aggravated by therapy for hypercortisolism in adrenocortical carcinoma
- Efficacy and safety of pralsetinib in multiple endocrine neoplasia type 2-associated pheochromocytoma: a case report
- Prospective multicenter evaluation of glycemic and patient-reported outcomes following transition to a next-generation continuous glucose monitoring system in users of advanced hybrid closed-loop technology
- Accuracy and feasibility of real-time continuous glucose monitoring in early postoperative intensive care after liver transplantation
- Diabetes mellitus in SHORT syndrome managed with multi-agent oral therapies: a case report and literature review
- Coexistence of familial dysalbuminemic hyperthyroixinemia and papillary thyroid carcinoma: a rare case report and diagnostic challenge
- Recent progress of remission in type 2 diabetes
- GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications
- The burden of metabolic diseases in the Arab region, 1990–2021
- Leave no bone unturned: metabolic bone disease in special populations
- Endocrine complications in patients with β-thalassemia major receiving iron-chelation therapy